DR. JOSEPH HANDEL CALLICOTT, M.D.
Psychiatric at Worthington Dr, Bethesda, MD
License number
Maryland D0047846
Category
Psychiatric
Type
Psychiatry
Address
Address
5012 Worthington Dr, Bethesda, MD 20816
Phone
(301) 320-0399
Personal information
See more information about JOSEPH HANDEL CALLICOTT at radaris.comName
Address
Phone
5012 Worthington Dr, Bethesda, MD 20816
Glen Echo, MD
3916 West Hwy, Chevy Chase, MD 20815
5012 Worthington Dr, Bethesda, MD 20816
3916 West Ave, Chevy Chase, MD 20815
Professional information
Effect Of Comt Genotype On Frontal Lobe Function
US Patent:
2003010, May 29, 2003
Filed:
May 10, 2002
Appl. No.:
10/144000
Inventors:
Daniel Weinberger - Washington DC, US
Michael Egan - Chevy Chase MD, US
Terry Goldberg - Bethesda MD, US
Joseph Callicott - Bethesda MD, US
David Goldman - Potomac MD, US
Michael Egan - Chevy Chase MD, US
Terry Goldberg - Bethesda MD, US
Joseph Callicott - Bethesda MD, US
David Goldman - Potomac MD, US
International Classification:
A61K031/00, C12Q001/68
US Classification:
514/001000, 435/006000
Abstract:
The invention provides a method of detecting impaired prefrontal cognitive function in an individual by determining the individual's COMT genotype, and associating a high activity Val allele with impaired prefrontal cognitive function (and a low activity Met allele with enhanced prefrontal cognitive function).
Effect Of Comt Genotype On Frontal Lobe Function
US Patent:
2006016, Jul 27, 2006
Filed:
Mar 31, 2006
Appl. No.:
11/395043
Inventors:
Daniel Weinberger - Washington DC, US
Michael Egan - Chevy Chase MD, US
Terry Goldberg - Bethesda MD, US
Joseph Callicott - Bethesda MD, US
David Goldman - Potomac MD, US
Michael Egan - Chevy Chase MD, US
Terry Goldberg - Bethesda MD, US
Joseph Callicott - Bethesda MD, US
David Goldman - Potomac MD, US
International Classification:
C12Q 1/68
US Classification:
435006000
Abstract:
The invention provides a method of detecting impaired prefrontal cognitive function in an individual by determining the individual's COMT genotype, and associating a high activity Val allele with impaired prefrontal cognitive function (and a low activity Met allele with enhanced prefrontal cognitive function).
Effect Of Bdnf Genotype On Hippocampal Function And Verbal Memory And Risk For Schizophrenia
US Patent:
2005001, Jan 20, 2005
Filed:
Feb 27, 2004
Appl. No.:
10/789169
Inventors:
Daniel Weinberger - Washington DC, US
Michael Egan - Chevy Chase MD, US
Bhaskar Kolachana - Oakton VA, US
David Goldman - Potomac MD, US
Joseph Callicott - Bethesda MD, US
Terry Goldberg - Bethesda MD, US
Michael Egan - Chevy Chase MD, US
Bhaskar Kolachana - Oakton VA, US
David Goldman - Potomac MD, US
Joseph Callicott - Bethesda MD, US
Terry Goldberg - Bethesda MD, US
International Classification:
C12Q001/68
US Classification:
435006000
Abstract:
The invention is related to the discovery that a met66val polymorphism in the gene for brain-derived neurotrophic factor (BDNF) is correlated with hippocampal function and verbal memory and risk for neuropsychiatric disorders such as schizophrenia.